People who started statins soon after a type 2 diabetes diagnosis had a meaningfully lower risk of developing dementia, a large Danish study reports — adding to evidence that managing cholesterol early may help protect the brain.
Researchers from Copenhagen University Hospital followed 132,585 people with no prior statin use who developed type 2 diabetes between 2006 and 2019, using Denmark’s national health registers. Those who began statins within one year of diagnosis had a 15% lower relative risk of dementia over 10 years versus non-users; starting 1–5 years later was linked to a smaller 10% reduction. The findings appeared in The Lancet Regional Health – Europe and were presented at ESC Congress 2026.
The important caveat
This is an observational study. Even though the team used a “clone-censor-weight” design to emulate a randomized trial and reduce bias, it cannot prove statins directly prevent dementia — only that early use was associated with lower risk. People who start statins promptly may differ in other ways that also affect dementia risk.
Why it matters
High LDL cholesterol from midlife is a recognized modifiable dementia risk factor, and people with type 2 diabetes often have both elevated LDL and higher cognitive-decline risk. The researchers note statins “seem to be underused” in this group despite clear cardiovascular benefits — so the brain angle may be one more reason not to delay. This summarizes research and is not medical advice; decisions about statins belong with your doctor.